New Delhi, May 31, 2017: Rohto Pharmaceutical Company Limited Japan, today, announced a Capital and Business Alliance with SastaSundar Health buddy Limited, a leading digital network of healthcare in India. Under the alliance, Rohto has invested Rs 32.4 crore in SastaSundar Health buddy Limited and is likely to make further investments as the business progresses. Announcing the alliance Lekh Raj Juneja, Executive Vice-President & Global Head International Business of Rohto said that his company initially played a role in every customer’s welfare with its drugs including unique eye drops and gastrointestinal medicines. Later, the company successfully ventured into dermal medicines, skin care, and functional foods. Rohto, a global leader, selling and marketing its products in more than 120 countries, aspires to become a company that challenges itself for “healthy life span” through both advanced life science and daily lifestyle based on technological expertise. Rohto entered India in 2010, by establishing its wholly-owned subsidiary ‘Rohto Pharma (India) Pvt. Ltd.’, with its leading lip care brand ‘LipIce’. The following year it launched a range of products including ‘LipIce Color’ under its brand ‘LipIce’. Subsequently, it launched two new brands ‘OXY’ specialised skin care range for men, and ‘Acnes’ for specialised acne care, in India. SastaSundar aims to have a total of 250 Health buddy stores in West Bengal and 50 Health buddy stores in Delhi by March 2018. “By utilising the network of SastaSundar we will be introducing well-acclaimed products from our global brands in the healthcare segment in India. This will also help us in expanding our footprints in India, which is a key emerging market for us”, added Dr Juneja.
United News Of India
